Table 1. Demographic and clinical characteristics of the study population (n=100).

Characteristics	Mean ± SD	n [%]
Quantitative
Age (years)	7.6±3.2
Age at diagnosis (years)	3.4±3.3
Time elapsed since diagnosis (years)	4.2±2.7
Duration on treatment (years)	4.09±2.4
Hemoglobin level (g/dL) (n=44)	11.4±1.5
Mean weight (kg)	23.7±8.0
Mean height (cm)	119.1±18.3
Qualitative
CD4 count
>25%		57 [57]
15-24%		12 [12]
<15%		7 [7]
Unknown		24 [24]
WHO clinical stage
Stage I		1 [1]
Stage II		22 [22]
Stage III		44 [44]
Stage IV		33 [33]
ARV protocol at inclusion
None		9 [9]
2INRT + 1INNRT		79 [79]
2INRT + 1IP		12 [12]
Protocol with AZT		82 [82]
Past history of tuberculosis		7 [7]
Past history of diagnosed pneumocystosis		0 [0]

SD, standard deviations; WHO, World Health Organization; ARV, antiretroviral.